{"id":54020,"date":"2023-02-16T20:03:06","date_gmt":"2023-02-16T19:03:06","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/lazurite-names-physicians-to-medical-advisory-board\/"},"modified":"2023-02-16T20:03:06","modified_gmt":"2023-02-16T19:03:06","slug":"lazurite-names-physicians-to-medical-advisory-board","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/lazurite-names-physicians-to-medical-advisory-board\/","title":{"rendered":"Lazurite\u00ae Names Physicians to Medical Advisory Board"},"content":{"rendered":"
\n

CLEVELAND–(BUSINESS WIRE)–#Biomedevice<\/a>–Medical device and technology company Lazurite today announced that Laith Jazrawi, M.D. and Mark Schickendantz, M.D. have joined the company\u2019s medical advisory board.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\nDr. Jazrawi is a professor of surgery with the department of orthopedic surgery at NYU Grossman School of Medicine and the chief of the division of sports medicine at NYU Langone. He serves as a team physician for the NYU and Long Island University athletics organization. His clinical research focuses on improving treatments for complex problems affecting the shoulder, elbow, and knee. He performed the first-in-man surgery using the ArthroFree System in September 2022.\n<\/p>\n

\nDr. Schickendantz is an orthopedic sports medicine surgeon at the Cleveland Clinic and Professor of Surgery at the Cleveland Clinic Lerner College of Medicine. He serves as Head Team Physician and Director of Orthopedic Services for the Cleveland Guardians.\n<\/p>\n

\n\u201cWe are delighted to have Drs. Jazrawi and Schickendantz join our team,\u201d Lazurite CEO and cofounder Eugene Malinskiy said. \u201cThey have both added tremendous value in the product refinement of the ArthroFree\u00ae Wireless Surgical Camera System for our first target market of orthopedics and, particularly sports medicine.\u201d\n<\/p>\n

\nThe ArthroFree System is the first wireless surgical camera to receive market clearance from the U.S. Food and Drug Administration for arthroscopy and general endoscopy. By eliminating conventional camera cables that tether surgeons to the surgical tower and hinder their movement, the ArthroFree System is expected to increase OR efficiency, improve OR safety and lower customer costs. More than 75 surgeries have now been performed using the ArthroFree System.\n<\/p>\n

\n\u201cI\u2019ve had the opportunity to use the ArthroFree camera in numerous surgeries in the last several months and provide feedback to the Lazurite team,\u201d Jazrawi said. \u201cI look forward to joining the advisory board and helping to launch the era of wireless visualization in surgery.\u201d\n<\/p>\n

\n\u201cI\u2019m excited about joining the Lazurite team as the company brings the ArthroFree System to market,\u201d Schickendantz said.\n<\/p>\n

\nJazrawi earned his medical degree from Icahn School of Medicine at Mt. Sinai in New York. He completed his residency in orthopedic surgery at NYU Medical Center and held a fellowship in Sports Medicine at American Sports Medicine Institute in Alabama. He is a member of a number of professional and medical societies, including the American Board of Orthopedic Surgery, the Arthroscopy Association of North America, and the American Orthopaedic Society for Sports Medicine. He is a fellow with the American Academy of Orthopedic Surgeons. He has a strong research interest in arthroscopic techniques, shoulder, elbow and knee disorders, cartilage repair, running injuries and maximizing athletic performance and has published nearly 300 peer-reviewed articles. He is the principal investigator on a comparative analysis study of the clinical use of the ArthroFree\u00ae Wireless Surgical Camera compared to wired surgical cameras.\n<\/p>\n

\nSchickendantz earned his medical degree from Saint Louis University School of Medicine in St. Louis. He completed an internship in general surgery and residency in orthopedic surgery at Cleveland Clinic and held a fellowship in shoulder surgery and sports medicine at the Steadman Hawkins Clinic in Vail, Colo. He is a member of a number of professional and medical societies, including the American Board of Orthopedic Surgery, a fellow with the American Academy of Orthopedic Surgeons and the Major League Baseball Team Physicians Association, among many others. He has published nearly 100 peer-reviewed articles, has written book chapters and has presented at various research meetings. He is an investor in Lazurite.\n<\/p>\n

\nAbout Lazurite<\/b>\n<\/p>\n

\nLazurite is a medical device and technology company. Its ArthroFree\u00ae System\u2014the wireless camera for arthroscopy and general endoscopy\u2014is designed for surgeons seeking surgical tools for greater agility in the OR. ArthroFree is drop-in compatible with current OR technologies, and it promises to eliminate cable-related patient burns, OR fires, and staff trips and falls. With the ArthroFree System, Lazurite ushers in the wireless era of surgical visualization. Lazurite\u2019s intellectual property portfolio also includes the low-heat Meridiem light technology and products in development. The pre-revenue company is located in Cleveland, OH (est. 2015), and to date has raised ~$25M from institutional investors, family offices, and more than 70 physician champions. The mission: solve impossible problems to improve people\u2019s lives. The 10-year vision: better outcomes for 1 million patients\u2014and thousands of clinicians, too. For more information, see: https:\/\/lazurite.co<\/a>\n<\/p>\n

\nForward-Looking Statements<\/b>\n<\/p>\n

\nThis press release includes \u201cforward-looking statements.\u201d Forward-looking statements can be identified by words such as: \u201canticipate,\u201d \u201cintend,\u201d \u201cexpect,\u201d \u201cmay,\u201d \u201cshould,\u201d \u201cwill,\u201d \u201cdesigned,\u201d \u201cpromises,\u201d and similar references to future periods. Examples of forward-looking statements include, among others, statements we make regarding the expected impact of the ArthroFree System on the field of minimally invasive surgery, and particularly arthroscopic surgery, and our future sales of the ArthroFree System. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations, and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy, and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.\n<\/p>\n

\nLazurite\u00ae, ArthroFree\u00ae, and Meridiem\u00ae are registered trademarks of Lazurite Holdings LLC.\n<\/p>\n

\nMedia Center<\/b>\n<\/p>\n

\nVisit lazurite.co\/media<\/a> <\/b>for videos, logos, images, fact sheets, bios and more.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nPatrick Gallagher
\n
+1 (216) 233-7473
\n
p.gallagher@lazurite.co<\/a>\n<\/p>\n

\nLazurite:
\n
+1 (216) 334-3127
\n
contact@lazurite.co<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

CLEVELAND–(BUSINESS WIRE)–#Biomedevice–Medical device and technology company Lazurite today announced that Laith Jazrawi, M.D. and Mark Schickendantz, M.D. have joined the company\u2019s medical advisory board. Dr. Jazrawi is a professor of surgery with the department of orthopedic surgery at NYU Grossman School of Medicine and the chief of the division of sports medicine at NYU Langone. … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-54020","6":"format-standard","7":"category-industry"},"yoast_head":"\nLazurite\u00ae Names Physicians to Medical Advisory Board - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/lazurite-names-physicians-to-medical-advisory-board\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lazurite\u00ae Names Physicians to Medical Advisory Board - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"CLEVELAND–(BUSINESS WIRE)–#Biomedevice–Medical device and technology company Lazurite today announced that Laith Jazrawi, M.D. and Mark Schickendantz, M.D. have joined the company\u2019s medical advisory board. Dr. Jazrawi is a professor of surgery with the department of orthopedic surgery at NYU Grossman School of Medicine and the chief of the division of sports medicine at NYU Langone. ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/lazurite-names-physicians-to-medical-advisory-board\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-16T19:03:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230216005623\/en\/1716246\/21\/Dr._Jazrawi.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lazurite-names-physicians-to-medical-advisory-board\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lazurite-names-physicians-to-medical-advisory-board\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Lazurite\u00ae Names Physicians to Medical Advisory Board\",\"datePublished\":\"2023-02-16T19:03:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lazurite-names-physicians-to-medical-advisory-board\\\/\"},\"wordCount\":990,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lazurite-names-physicians-to-medical-advisory-board\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230216005623\\\/en\\\/1716246\\\/21\\\/Dr._Jazrawi.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lazurite-names-physicians-to-medical-advisory-board\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lazurite-names-physicians-to-medical-advisory-board\\\/\",\"name\":\"Lazurite\u00ae Names Physicians to Medical Advisory Board - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lazurite-names-physicians-to-medical-advisory-board\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lazurite-names-physicians-to-medical-advisory-board\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230216005623\\\/en\\\/1716246\\\/21\\\/Dr._Jazrawi.jpg\",\"datePublished\":\"2023-02-16T19:03:06+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lazurite-names-physicians-to-medical-advisory-board\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lazurite-names-physicians-to-medical-advisory-board\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lazurite-names-physicians-to-medical-advisory-board\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230216005623\\\/en\\\/1716246\\\/21\\\/Dr._Jazrawi.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230216005623\\\/en\\\/1716246\\\/21\\\/Dr._Jazrawi.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lazurite-names-physicians-to-medical-advisory-board\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lazurite\u00ae Names Physicians to Medical Advisory Board\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lazurite\u00ae Names Physicians to Medical Advisory Board - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/lazurite-names-physicians-to-medical-advisory-board\/","og_locale":"en_US","og_type":"article","og_title":"Lazurite\u00ae Names Physicians to Medical Advisory Board - Pharma Trend","og_description":"CLEVELAND–(BUSINESS WIRE)–#Biomedevice–Medical device and technology company Lazurite today announced that Laith Jazrawi, M.D. and Mark Schickendantz, M.D. have joined the company\u2019s medical advisory board. Dr. Jazrawi is a professor of surgery with the department of orthopedic surgery at NYU Grossman School of Medicine and the chief of the division of sports medicine at NYU Langone. ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/lazurite-names-physicians-to-medical-advisory-board\/","og_site_name":"Pharma Trend","article_published_time":"2023-02-16T19:03:06+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230216005623\/en\/1716246\/21\/Dr._Jazrawi.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/lazurite-names-physicians-to-medical-advisory-board\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/lazurite-names-physicians-to-medical-advisory-board\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Lazurite\u00ae Names Physicians to Medical Advisory Board","datePublished":"2023-02-16T19:03:06+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/lazurite-names-physicians-to-medical-advisory-board\/"},"wordCount":990,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/lazurite-names-physicians-to-medical-advisory-board\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230216005623\/en\/1716246\/21\/Dr._Jazrawi.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/lazurite-names-physicians-to-medical-advisory-board\/","url":"https:\/\/pharma-trend.com\/en\/lazurite-names-physicians-to-medical-advisory-board\/","name":"Lazurite\u00ae Names Physicians to Medical Advisory Board - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/lazurite-names-physicians-to-medical-advisory-board\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/lazurite-names-physicians-to-medical-advisory-board\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230216005623\/en\/1716246\/21\/Dr._Jazrawi.jpg","datePublished":"2023-02-16T19:03:06+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/lazurite-names-physicians-to-medical-advisory-board\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/lazurite-names-physicians-to-medical-advisory-board\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/lazurite-names-physicians-to-medical-advisory-board\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230216005623\/en\/1716246\/21\/Dr._Jazrawi.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230216005623\/en\/1716246\/21\/Dr._Jazrawi.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/lazurite-names-physicians-to-medical-advisory-board\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Lazurite\u00ae Names Physicians to Medical Advisory Board"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54020","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=54020"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54020\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=54020"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=54020"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=54020"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}